NC-PERCONA
17.5.2022 18:06:05 CEST | Business Wire | Press release
Percona , a leader in open source database software and services, today announced the general availability of Percona Platform , which brings the company’s expertise with databases including MySQL®, PostgreSQL® and MongoDB® together alongside services, management and automated insights into a single product. Using the company’s experience in managing and improving some of the largest database installations in the world, Percona Platform helps users monitor, manage, secure and optimize their database instances across any infrastructure.
“Percona Platform brings the experience and expertise that we have built up over the years and puts it in the hands of developers and database administrators to use. It includes AI-powered recommendations that help users improve performance, management and security, as well as making it easier to scale up and manage their instances over time. With Percona Platform, we thought about how to improve the experience for developers and DBAs around running their data workloads, and how to help people achieve their goals faster around managing databases as part of their overall approach,” said Donnie Berkholz, Senior Vice President Product at Percona.
“Developers want to improve their efficiency and experience across their tasks, and databases are no exception. Improving this will be an area of investment for companies - whether this involves time for their staff to implement projects, or investing in cloud services to provide the tools they need. Percona’s approach to this challenge aims to provide self-managed control and internal ownership as well as the flexibility and ease of use that many companies tout with their DBaaS offerings. By offering a fully open source compatible service, Percona is looking to plug a gap in the market that many database companies are not able to cover,” commented Bradley Shimmin, Chief Analyst, AI platforms, analytics and data management at Omdia.
“There has been an explosion of data tools available to enterprises, which in turn has led to rampant fragmentation and highly complex, disjointed workflows. Organizations that prize velocity are looking for ways to integrate various data tools into their broader development workflows and monitor them. This is the opportunity that Percona Platform is built for. The combination of software and services in this space is intended to help customers better manage their database deployments,” commented Rachel Stephens, Senior Analyst, RedMonk.
“Percona has woven over a decade of open-source database expertise into a consistent, modern database experience for all organizations, from any cloud to on-premises. With Percona Platform we have built out our open source database software offerings, bolstered by automated insights, self-service operations, and the best database observability and management tools in the market. This launch will help us scale our business and create a sustainable model in the age of cloud, while respecting the freedom and accessibility that is open source. We have seen other companies turn away from open source and adopt closed source licenses in order to maximize their profitability, which we think is not in the best interests of customers. Our approach makes our expertise available to all our customers and users, putting their needs first,” added Ann Schlemmer, President at Percona.
Percona Platform is the culmination of the company’s work to expand and deliver its wide-ranging knowledge of databases into products that users can deploy quickly and use to improve their performance. As part of the launch, Percona has used its service expertise to create automated recommendation products called Advisors for customers that can help them immediately improve their results. It supports all deployment configurations, from public, private and hybrid cloud instances through to internal data center deployments. It supports both self-managed and Percona-managed instances, letting customers approach their database management in the way that suits them.
Percona Platform includes the following elements:
- Percona Portal - access to all Percona services and product expertise through one unified online portal, covering multiple databases with enterprise-level features including backup, security, management, optimization and more
- Percona Monitoring and Management (PMM) - a database management product that is fully open source itself, allowing developers and DBAs to streamline their management tasks across multiple platforms from one place
- New range of Advisors - automated insights that ensure user databases are performing at their best, including security management, configuration and performance improvements
- Private DBaaS Technical Preview - this will support companies deploying their own DBaaS internally using open source database distributions, Percona management tool PMM and Kubernetes operators for MySQL and PostgreSQL. It will also support the same approach for MongoDB. This enables users to easily provision and manage database instances on a self-service basis across development and testing instances, improving the experience for developers
- Percona Account - simplified user account management for all Percona products and services under one account
Links
- Percona Platform - https://www.percona.com/software/percona-platform
About Percona
Databases run better with Percona. Percona is the only company that delivers enterprise-class products, support and services for a range of open source databases including MySQL®, MariaDB®, MongoDB®, and PostgreSQL across traditional deployments, cloud-based platforms and hybrid IT environments. The company is committed to supporting open source as an approach to software licensing, development and deployment - its database management tools are used by millions of application developers, database administrators and IT professionals worldwide.
Percona equips businesses with the freedom to choose, the freedom to create, and the freedom to make a difference — helping them scale with speed as they grow. The company supports global brands such as PayPal, Vimeo, RockStar Games, Duolingo, Fiserv, Slack, Cisco Systems, and Rent the Runway, as well as smaller enterprises looking to maximize application performance while streamlining database efficiencies. For more information, visit www.percona.com .
Percona® is a registered trademark of Percona LLC. All other registered and unregistered trademarks in this document are the sole property of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220517006011/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
